Challenges in measuring and valuing productivity costs, and their relevance in mood disorders

Abstract

Benedikte R Lensberg,1 Michael F Drummond,2 Natalya Danchenko,3 Nicolas Despiégel,4 Clément François3 1OptumInsight, Uxbridge, 2Centre for Health Economics, University of York, York, UK; 3Lundbeck SAS, Issy-les-Moulineaux, 4OptumInsight, Nanterre, France Abstract: Lost productivity is often excluded from economic evaluations, which may lead to an underestimation of the societal benefits of treatment. However, there are multiple challenges in reliably estimating and reporting productivity losses. This article explores the main challenges, ie, selecting an appropriate valuation method (ie, human capital, friction cost, or multiplier), avoiding double counting, and accounting for equity. It also discusses the use of presenteeism instruments and their application in clinical trials, with a specific focus on their relevance in individuals with mood disorders. Further research and discussion is required on the development of reliable techniques for measuring and valuing productivity changes due to presenteeism. Keywords: mood disorders, cost-benefit analysis, technology assessment, biomedical, presenteeism, absenteeism, productivity loss